The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Collaboration to deliver scalable automation solutions for electronics, semiconductor, medical manufacturing, and intralogistics sectors
Initiatives include scholarships, STEM initiatives, and healthcare capacity-building programmes supporting women and girls across 52 countries
Paves way for CNS cancer test rollout
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
Strong export-led growth and improved profitability as the company focuses on CNS drug development and global regulatory footprint
Subscribe To Our Newsletter & Stay Updated
